- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies ; volume:10 ; number:1 ; day:19 ; month:9 ; year:2013 ; pages:1 ; date:9.2013
Retrovirology ; 10, Heft 1 (19.9.2013), 1, 9.2013
- Urheber
-
Martin, Malcolm A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-10-S1-O41
- URN
-
urn:nbn:de:1111-2016080731053
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Martin, Malcolm A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma
Broadly Neutralizing Antibodies for HIV Eradication
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
The expanding array of HIV broadly neutralizing antibodies
Model-based anti-HIV therapy
In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma
Broadly Neutralizing Antibodies for HIV Eradication
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
The expanding array of HIV broadly neutralizing antibodies
Model-based anti-HIV therapy
In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma
Broadly Neutralizing Antibodies for HIV Eradication
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
The expanding array of HIV broadly neutralizing antibodies
Model-based anti-HIV therapy
In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies